Patient walking during ambulatory immunotherapy

Hospital pharmacist Dr. Roelof van Leeuwen, who works in the Department of Pharmacy and Internal Oncology at the Erasmus MC Cancer Institute, has a mission. He wants health care to be accessible and work manageable for health workers. Projects on which she collaborates with other specialists, nurses and pharmacy assistants will help. Patients themselves play … Read more

IF you don’t get better!

Sebastiaan Kuiken, our son and brother (age 40), was diagnosed with ALS this year. ALS is one of the most serious and progressive disorders of the nervous system, in which all muscles gradually fail. Your life will literally fall apart! Sebastian was: strong as a bear, athletic, positive and willing. He was super handy. In … Read more

Better treatment strategies for children with heart defects through international collaboration

Thanks to the international network CAHAL*, new scientific findings are quickly implemented at LUMC and Amsterdam UMC Professors Mark Hazekamp and Nico Blom strive to push the boundaries of pediatric cardiology every day. By continuously improving quality guidelines in research, education and patient care, they contribute to improving the diagnosis and treatment of (congenital) heart … Read more

IF you don’t get better!

Sebastiaan Kuiken, our son and brother (age 40), was diagnosed with ALS this year. ALS is one of the most serious and progressive disorders of the nervous system, in which all muscles gradually fail. Your life will literally fall apart! Sebastian was: strong as a bear, athletic, positive and willing. He was super handy. In … Read more

The Kidney Foundation presents a check for nephrotic syndrome research

November 17, 2022 On November 14, researcher Dr. Rutger Maas from Radboudumc a check from the Dutch Kidney Foundation for nephrotic syndrome research. The donation was made possible through the estate of Janneke Bresser’s mother, a patient treated by Dr. Mesh. Arjen Rienks, research program manager at the Dutch Kidney Foundation, presented a check for … Read more

FDA approves diabetes drug Tzield

On November 17, 2022, the US Food and Drug Administration approved Tzield injection (teplizumab-mzwv) to delay the onset of type 1 diabetes in adults and pediatric patients 8 years of age and older who currently have type 2 diabetes. “Today’s approval of a first-in-class therapy adds an important new treatment option for some at-risk patients‘ … Read more

Premature babies have been monitored for forty years

A large study of the long-term consequences of preterm birth is underway About 7 percent of babies are born prematurely in the Netherlands every year, and it’s even 10 percent worldwide. November 17, 2022 was all about these babies, then it is the World Day of Premature Babies. TNO has been using the POPS study … Read more

Transforming care in practice at Laurens

The transformation of healthcare requires not only digitization and innovation, but also a change in thinking. Or, for example, as Nicole Lentinková from Deloitte says: “We need to move from an ecosystem of care to an ecosystem of health. Judith Terwijn and Onno Kleinhorst support this approach, in which not only diseases are treated, but … Read more